Cargando…
Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer
Inflammation plays a crucial role in the pathogenesis of cancer with tumor necrosis factor‐α (TNF‐α) as a key mediator. Recently, spermatogenesis‐associated protein 2 (SPATA2) was identified as a TNF receptor modulator which is required for TNF‐induced inflammation and apoptosis. The available data...
Autores principales: | Wieser, Verena, Tsibulak, Irina, Degasper, Christine, Welponer, Hannah, Leitner, Katharina, Parson, Walther, Zeimet, Alain G., Marth, Christian, Fiegl, Heidelinde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398874/ https://www.ncbi.nlm.nih.gov/pubmed/30697874 http://dx.doi.org/10.1111/cas.13955 |
Ejemplares similares
-
The miR-34 family and its clinical significance in ovarian cancer
por: Welponer, Hannah, et al.
Publicado: (2020) -
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in
ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2018) -
Clinical Impact of RANK Signalling in Ovarian Cancer
por: Wieser, Verena, et al.
Publicado: (2019) -
Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Leitner, Katharina, et al.
Publicado: (2020) -
BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2018)